2019
DOI: 10.5582/ddt.2019.01065
|View full text |Cite
|
Sign up to set email alerts
|

Different activities of antitumor immunomodulators to induce neutrophil adherence response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…It has been reported that Nr-CWS is not only an immunomodulator but also an anti-tumor agent [ 27 ], consisting of arabinogalactan, mycolic acid and mucopeptide and enhancing the ability of the host to clear infection. Studies have demonstrated that Nr-CWS has antitumor [ 14 ], immune response regulation [ 23 , 29 , 50 ], angiogenesis and cutaneous wound healing promoting properties [ 51 ]. A study proved that treatment with Nr-CWS could reduce Programmed cell death 1 ligand 1 (PD-L1) in tumor tissues and provide the possibility for the combination of Nr-CWS with PD-1/PD-L1 antibodies [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been reported that Nr-CWS is not only an immunomodulator but also an anti-tumor agent [ 27 ], consisting of arabinogalactan, mycolic acid and mucopeptide and enhancing the ability of the host to clear infection. Studies have demonstrated that Nr-CWS has antitumor [ 14 ], immune response regulation [ 23 , 29 , 50 ], angiogenesis and cutaneous wound healing promoting properties [ 51 ]. A study proved that treatment with Nr-CWS could reduce Programmed cell death 1 ligand 1 (PD-L1) in tumor tissues and provide the possibility for the combination of Nr-CWS with PD-1/PD-L1 antibodies [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…The Nocardia rubra cell wall skeleton (Nr-CWS), an innate immunomodulatory and antitumor agent [ 14 , 21 ], was first reported in 1976 by Azuma et al . [ 22 ].…”
Section: Introductionmentioning
confidence: 99%